As of Dec 01
| +0.71 / +1.26%|
The 1 analysts offering 12-month price forecasts for Utah Medical Products Inc have a median target of 65.23, with a high estimate of 65.23 and a low estimate of 65.23. The median estimate represents a +14.04% increase from the last price of 57.20.
The current consensus among 1 polled investment analysts is to Buy stock in Utah Medical Products Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.